We offer compounded Semaglutide and Tirzepatide treatments tailored specifically to your body's needs and response
A 2022 study in International Journal of Molecular Sciences (Sikiric et al.) found BPC-157 reduced pro-inflammatory cytokines including TNF- and IL-6 while increasing anti-inflammatory cytokines (IL-10), creating a balanced immune response rather than simply suppressing immunity
However, there are some exceptions and drugs for weight loss are one of those exceptions
We carry and administer the same hospital-grade ingredients, supplies, and equipment with all our drips, boosters, and shots
But at the same time, CMS has expanded the Medicare GLP-1 Bridge Program, which now runs July 1, 2026 through December 31, 2027 for eligible Medicare Part D beneficiaries